SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX

This adverse event was reported 32 times

These drugs are most commonly taken by patients reporting SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX:

# Drug Count
0 LENALIDOMIDE 13
1 DEXAMETHASONE 6
2 DEXAMETHASONE 1.5 MG 6
3 BORTEZOMIB 4
4 CARFILZOMIB 4
5 MYCOPHENOLATE MOFETIL 4
6 ASPIRIN 3
7 ASPIRIN 325 MG 3
8 ASPIRIN 81 MG 3
9 BISOPROLOL FUMARATE 3
See all common drugs associated with SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX

SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PROBENECID 1 0.0008
1 CISATRACURIUM BESYLATE 1 0.0004
2 LIDOCAINE HCL 1 0.0004
3 PYRIDOSTIGMINE BROMIDE ORAL 1 0.0003
4 NICARDIPINE 1 0.0002
5 ACITRETIN 1 0.0002
6 GLYCOPYRROLATE 1 0.0002
7 CARFILZOMIB 4 0.0001
8 MELPHALAN HYDROCHLORIDE 3 0.0001
9 TRANEXAMIC ACID 1 0.0001
See all drugs enriched for association with SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX

SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 1 0.0002
1 Sigma-1 Agonist [EPC] 1 0.0001
2 Antifibrinolytic Agent [EPC] 1 0.0001
3 Proteasome Inhibitor [EPC] 8 0.0001
4 Stimulant Laxative [EPC] 1 0.0001
5 Vitamin D3 Analog [EPC] 1 0.0000
6 Antimetabolite Immunosuppressant [EPC] 1 0.0000
7 Interleukin-23 Antagonist [EPC] 3 0.0000
8 Interleukin-17A Antagonist [EPC] 1 0.0000
9 Thalidomide Analog [EPC] 13 0.0000
See all drug classes enriched for association with SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX